Sustained release was one of the first approaches to be assessed in clinical trials, and led to approval of the encapsulated formulation of exenatide: exenatide extended release (ER) (47)
For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Lincoff adds that it was known that semaglutide could help reduce the risk of cardiovascular events in those with diabetes, but it was unclear if that would also be the case in those without diabetes
Sex and other factors which can impact your weight can also lead to an inaccurate reading
Wegovy continues escalating) Months 46 (Wegovy only): 1.7 mg 2.4 mg weekly maintenance dose Clinical data from the STEP 5 trial (2-year follow-up) showed that the majority of participants tolerated semaglutide well in the long term, with fewer than 4% discontinuing due to side effects
While its a proven method, some people struggle with consistency, leading to slow or minimal results